JP2021535159A5 - - Google Patents

Info

Publication number
JP2021535159A5
JP2021535159A5 JP2021510960A JP2021510960A JP2021535159A5 JP 2021535159 A5 JP2021535159 A5 JP 2021535159A5 JP 2021510960 A JP2021510960 A JP 2021510960A JP 2021510960 A JP2021510960 A JP 2021510960A JP 2021535159 A5 JP2021535159 A5 JP 2021535159A5
Authority
JP
Japan
Prior art keywords
compound
formula
alkyl
group
haloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021510960A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021535159A (ja
JP7583710B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/048408 external-priority patent/WO2020046991A1/en
Publication of JP2021535159A publication Critical patent/JP2021535159A/ja
Publication of JP2021535159A5 publication Critical patent/JP2021535159A5/ja
Priority to JP2024192796A priority Critical patent/JP2025016676A/ja
Application granted granted Critical
Publication of JP7583710B2 publication Critical patent/JP7583710B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021510960A 2018-08-27 2019-08-27 スパイン形成のためのファシン結合化合物 Active JP7583710B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024192796A JP2025016676A (ja) 2018-08-27 2024-11-01 スパイン形成のためのファシン結合化合物

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201862723381P 2018-08-27 2018-08-27
US62/723,381 2018-08-27
US201862726904P 2018-09-04 2018-09-04
US62/726,904 2018-09-04
US201862785435P 2018-12-27 2018-12-27
US62/785,435 2018-12-27
PCT/US2019/048408 WO2020046991A1 (en) 2018-08-27 2019-08-27 Fascin binding compounds for spinogenesis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024192796A Division JP2025016676A (ja) 2018-08-27 2024-11-01 スパイン形成のためのファシン結合化合物

Publications (3)

Publication Number Publication Date
JP2021535159A JP2021535159A (ja) 2021-12-16
JP2021535159A5 true JP2021535159A5 (enExample) 2022-08-25
JP7583710B2 JP7583710B2 (ja) 2024-11-14

Family

ID=69644570

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021510960A Active JP7583710B2 (ja) 2018-08-27 2019-08-27 スパイン形成のためのファシン結合化合物
JP2024192796A Pending JP2025016676A (ja) 2018-08-27 2024-11-01 スパイン形成のためのファシン結合化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024192796A Pending JP2025016676A (ja) 2018-08-27 2024-11-01 スパイン形成のためのファシン結合化合物

Country Status (7)

Country Link
US (2) US20210330646A1 (enExample)
EP (1) EP3843846A4 (enExample)
JP (2) JP7583710B2 (enExample)
CN (1) CN112912141B (enExample)
AU (1) AU2019329835B2 (enExample)
CA (1) CA3110877A1 (enExample)
WO (1) WO2020046991A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7168650B2 (ja) 2017-08-02 2022-11-09 スピノジェニックス, インコーポレイテッド ベンゾチアゾールおよび関連化合物
SMT202500291T1 (it) 2019-01-31 2025-09-12 Spinogenix Inc Forme solide di un promotore di spinogenesi
JP2023533016A (ja) 2020-07-11 2023-08-01 ファイザー・インク 抗ウイルス性ヘテロアリールケトン誘導体
US11351149B2 (en) 2020-09-03 2022-06-07 Pfizer Inc. Nitrile-containing antiviral compounds
EP4294391A4 (en) * 2021-02-22 2024-12-18 Spinogenix, Inc. METHODS OF TREATING SPINAL CORD INJURY OR DAMAGE
AU2022241760A1 (en) * 2021-03-23 2023-10-05 Spinogenix, Inc. Certain fascin binding compounds for spinogenesis
EP4687886A1 (en) * 2023-04-03 2026-02-11 Spinogenix, Inc. Methods of dosing spinogenic compounds
CN121773104A (zh) * 2023-06-30 2026-03-31 北京双鹤润创科技有限公司 肌成束蛋白抑制剂
WO2025184576A1 (en) * 2024-02-29 2025-09-04 Spinogenix, Inc. Methods for prevention and treatment of depression

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US4326525A (en) 1980-10-14 1982-04-27 Alza Corporation Osmotic device that improves delivery properties of agent in situ
US5364620A (en) 1983-12-22 1994-11-15 Elan Corporation, Plc Controlled absorption diltiazem formulation for once daily administration
US5023252A (en) 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
US5001139A (en) 1987-06-12 1991-03-19 American Cyanamid Company Enchancers for the transdermal flux of nivadipine
US4992445A (en) 1987-06-12 1991-02-12 American Cyanamid Co. Transdermal delivery of pharmaceuticals
US4902514A (en) 1988-07-21 1990-02-20 Alza Corporation Dosage form for administering nilvadipine for treating cardiovascular symptoms
CA2832439C (en) 2011-04-07 2017-08-29 Sloan-Kettering Institute For Cancer Research Migrastatins and uses thereof
WO2013013240A2 (en) 2011-07-21 2013-01-24 Theracrine, Inc. Macrocyclic compounds and related compositons and methods of use
IN2014DN01883A (enExample) * 2011-09-14 2015-05-15 Proximagen Ltd
ES2877570T3 (es) * 2012-08-22 2021-11-17 Univ Cornell Métodos para inhibir fascina
US9573946B2 (en) * 2014-02-20 2017-02-21 Novita Pharmaceuticals, Inc. Compounds and methods for inhibiting fascin
CA3010445A1 (en) 2016-01-05 2017-07-13 The Regents Of The University Of California Benzothiazole amphiphiles
TWI586367B (zh) 2016-03-28 2017-06-11 蔡懷楨 磷酸甘油酯激酶增加神經突生長及/或治療神經性疾病的用途
JP7168650B2 (ja) * 2017-08-02 2022-11-09 スピノジェニックス, インコーポレイテッド ベンゾチアゾールおよび関連化合物

Similar Documents

Publication Publication Date Title
JP2021535159A5 (enExample)
JP2021535104A5 (enExample)
JP2023514872A5 (enExample)
JP2022545359A5 (enExample)
JP2023529354A5 (enExample)
JP2013535460A5 (enExample)
JP2019517487A5 (enExample)
JP2009536620A5 (enExample)
JP2020533352A5 (enExample)
JP2023545396A5 (enExample)
JP2014521653A5 (enExample)
JP2011509309A5 (enExample)
JP2008509187A5 (enExample)
JP2004525179A5 (enExample)
JP2003521537A5 (enExample)
JP2004517087A5 (enExample)
JP2004511466A5 (enExample)
JP2011515482A5 (enExample)
JP2007508361A5 (enExample)
RU2013108702A (ru) Ингибиторы деметилазы lsd1 на основе арилциклопропиламина и их применение в медицине
JP2002536329A5 (enExample)
JP2019508496A5 (enExample)
JP2021511359A5 (enExample)
JP2021535134A5 (enExample)
JP2011517697A5 (enExample)